{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["42(2)"],"submitter":["Barresi V"],"pubmed_abstract":["We report a case of oligodendroglioma that had consistent histopathological features as well as a distinct change in 1p/19q status in the second recurrence, after temozolomide chemotherapy and radiotherapy. The first tumor recurrence had oligodendroglial morphology, IDH1 R132H and TERT promoter mutations, and 1p/19q codeletion detected by fluorescent in situ hybridization (FISH). Copy number analysis, assessed by next-generation sequencing, confirmed 1p/19q codeletion, and disclosed loss of heterozygosity (LOH) of chromosomes 4 and 9 and chromosome 11 gain. The second recurrence featured not only oligodendroglial morphology but also the appearance of admixed multinucleated giant cells or neoplastic cells having oval nuclei and mitoses and showing microvascular proliferation; it maintained "],"journal":["Neuropathology : official journal of the Japanese Society of Neuropathology"],"pagination":["160-166"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9546156"],"repository":["biostudies-literature"],"pubmed_title":["Recurrent oligodendroglioma with changed 1p/19q status."],"pmcid":["PMC9546156"],"pubmed_authors":["Mafficini A","Musumeci A","Barresi V","Piredda ML","Scarpa A","Calicchia M","Ghimenton C"],"additional_accession":[]},"is_claimable":false,"name":"Recurrent oligodendroglioma with changed 1p/19q status.","description":"We report a case of oligodendroglioma that had consistent histopathological features as well as a distinct change in 1p/19q status in the second recurrence, after temozolomide chemotherapy and radiotherapy. The first tumor recurrence had oligodendroglial morphology, IDH1 R132H and TERT promoter mutations, and 1p/19q codeletion detected by fluorescent in situ hybridization (FISH). Copy number analysis, assessed by next-generation sequencing, confirmed 1p/19q codeletion, and disclosed loss of heterozygosity (LOH) of chromosomes 4 and 9 and chromosome 11 gain. The second recurrence featured not only oligodendroglial morphology but also the appearance of admixed multinucleated giant cells or neoplastic cells having oval nuclei and mitoses and showing microvascular proliferation; it maintained ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-22T12:07:04.369Z","creation":"2025-04-06T00:15:13.422Z"},"accession":"S-EPMC9546156","cross_references":{"pubmed":["35144313"],"doi":["10.1111/neup.12789"]}}